Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel Kool

Showing results (141-150 of 337) with videos related to

Pageof 34
Sort By:
Molecular Oncology|September 13, 2020
Downregulation of miR-326 and its host gene β-arrestin1 induces pro-survival activity of E2F1 and promotes medulloblastoma growthEvelina Miele, Agnese Po, Angela Mastronuzzi, et al.
European Journal of Cancer (Oxford, England : 1990)|December 28, 2021
Target Actionability Review: a systematic evaluation of replication stress as a therapeutic target for paediatric solid malignanciesKaylee M Keller, Sonja Krausert, Apurva Gopisetty, et al.
Brain Pathology (Zurich, Switzerland)|October 10, 2017
Epithelioid glioblastomas stratify into established diagnostic subsets upon integrated molecular analysisAndrey Korshunov, Lukas Chavez, Tanvi Sharma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2021
Clinically Tractable Outcome Prediction of Non-WNT/Non-SHH Medulloblastoma Based on TPD52 IHC in a Multicohort StudyAlberto Delaidelli, Christopher Dunham, Mariarita Santi, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists|March 10, 2022
Rbbp4 loss disrupts neural progenitor cell cycle regulation independent of Rb and leads to Tp53 acetylation and apoptosisLaura E Schultz-Rogers, Michelle L Thayer, Sekhar Kambakam, et al.
Neuro-Oncology|April 28, 2021
Treatment of embryonal tumors with multilayered rosettes with carboplatin/etoposide induction and high-dose chemotherapy within the prospective P-HIT trialB-Ole Juhnke, Marco Gessi, Nicolas U Gerber, et al.
Neuro-Oncology|March 5, 2025
High-resolution proteomic analysis of medulloblastoma clinical samples identifies therapy resistant subgroups and MYC immunohistochemistry as a powerful outcome predictorAlberto Delaidelli, Fares Burwag, Susana Ben-Neriah, et al.
Acta Neuropathologica Communications|February 14, 2023
CNS tumor with EP300::BCOR fusion: discussing its prevalence in adult populationArnault Tauziède-Espariat, Emmanuelle Uro-Coste, Philipp Sievers, et al.
The EMBO Journal|September 15, 2016
FBW7 suppression leads to SOX9 stabilization and increased malignancy in medulloblastomaAldwin Suryo Rahmanto, Vasil Savov, Andrä Brunner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 25, 2010
Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcomeYoon-Jae Cho, Aviad Tsherniak, Pablo Tamayo, et al.
Pageof 34

Showing results (141-150 of 337) with videos related to

Sort By:
Pageof 34
Molecular Oncology|September 13, 2020
Downregulation of miR-326 and its host gene β-arrestin1 induces pro-survival activity of E2F1 and promotes medulloblastoma growthEvelina Miele, Agnese Po, Angela Mastronuzzi, et al.
European Journal of Cancer (Oxford, England : 1990)|December 28, 2021
Target Actionability Review: a systematic evaluation of replication stress as a therapeutic target for paediatric solid malignanciesKaylee M Keller, Sonja Krausert, Apurva Gopisetty, et al.
Brain Pathology (Zurich, Switzerland)|October 10, 2017
Epithelioid glioblastomas stratify into established diagnostic subsets upon integrated molecular analysisAndrey Korshunov, Lukas Chavez, Tanvi Sharma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2021
Clinically Tractable Outcome Prediction of Non-WNT/Non-SHH Medulloblastoma Based on TPD52 IHC in a Multicohort StudyAlberto Delaidelli, Christopher Dunham, Mariarita Santi, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists|March 10, 2022
Rbbp4 loss disrupts neural progenitor cell cycle regulation independent of Rb and leads to Tp53 acetylation and apoptosisLaura E Schultz-Rogers, Michelle L Thayer, Sekhar Kambakam, et al.
Neuro-Oncology|April 28, 2021
Treatment of embryonal tumors with multilayered rosettes with carboplatin/etoposide induction and high-dose chemotherapy within the prospective P-HIT trialB-Ole Juhnke, Marco Gessi, Nicolas U Gerber, et al.
Neuro-Oncology|March 5, 2025
High-resolution proteomic analysis of medulloblastoma clinical samples identifies therapy resistant subgroups and MYC immunohistochemistry as a powerful outcome predictorAlberto Delaidelli, Fares Burwag, Susana Ben-Neriah, et al.
Acta Neuropathologica Communications|February 14, 2023
CNS tumor with EP300::BCOR fusion: discussing its prevalence in adult populationArnault Tauziède-Espariat, Emmanuelle Uro-Coste, Philipp Sievers, et al.
The EMBO Journal|September 15, 2016
FBW7 suppression leads to SOX9 stabilization and increased malignancy in medulloblastomaAldwin Suryo Rahmanto, Vasil Savov, Andrä Brunner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 25, 2010
Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcomeYoon-Jae Cho, Aviad Tsherniak, Pablo Tamayo, et al.
Pageof 34